Femasys Inc (FEMY) CTO buys stock and receives milestone-based warrants
Rhea-AI Filing Summary
Femasys Inc Chief Technology Officer Jeremy Alexander Sipos reported multiple transactions involving the company’s equity. He purchased 3,125 shares of common stock at $3.20 per share, for an aggregate $10,000, under a Securities Purchase Agreement dated August 7, 2026. On the same date, he was granted a warrant for 3,125 shares of common stock at an exercise price of $2.95 per share, exercisable from August 10, 2026 until August 10, 2029, subject to Nasdaq Capital Market limitations. He also received a milestone warrant for 3,125 shares at $2.95 per share, exercisable only after a future Milestone Date tied to the company achieving $1,500,000 in U.S. revenue in any fiscal quarter and certain stock price conditions; the milestone warrant’s expiration is contingent and not yet determinable.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 3,125 shares
Net Buy
3 txns
Insider
Sipos Jeremy Alexander
Role
Chief Technology Officer
Bought
3,125 shs ($10K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Purchase Warrant F2, F4, F3 | 3,125 | -- | -- |
| Grant/Award | Common Stock Purchase Warrant (Milestone) F2, F4, F5, F3 | 3,125 | -- | -- |
| Purchase | Common Stock F1 | 3,125 | $3.20 | $10K |
Holdings After Transaction:
Common Stock Purchase Warrant — 3,125 shares (Direct);
Common Stock Purchase Warrant (Milestone) — 3,125 shares (Direct);
Common Stock — 3,125 shares (Direct)
Footnotes (5)
- F1. The purchase price paid by the reporting person for the Shares was $3.20 per share pursuant to the Securities Purchase Agreement, dated as of August 7, 2026, by and among Femasys Inc. and the purchasers party thereto.
- F2. Holder may, at its option, exercise the Common Warrant, subject to the terms and conditions thereof, at an exercise price of $2.95 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Common Warrant and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
- F3. The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.
- F4. The reported securities were purchased by the reporting person for an aggregate amount of $10,000.
- F5. The Common Warrant (Milestone) is exercisable only from and after the Milestone Date, being the first date on or after August 10, 2027 on which both (i) the Company has achieved U.S. revenue of $1,500,000 for any fiscal quarter, as reported in a Form 10-Q or Form 10-K, and (ii) the volume-weighted average price of the Common Stock has satisfied certain price conditions specified in the warrant. The warrant expires on the earlier of (i) three years after the effective date of a registration statement registering the resale of the Warrant Shares and (ii) 45 days after the Company delivers notice that the Milestone Date has occurred. As of the date of this report, neither the Milestone Date nor the expiration date is determinable.
Key Figures
Common shares purchased: 3,125 shares
Purchase price per share: $3.20 per share
Aggregate purchase amount: $10,000
+5 more
8 metrics
Common shares purchased
3,125 shares
Common stock purchase on August 7, 2026
Purchase price per share
$3.20 per share
Price paid for common stock under Securities Purchase Agreement
Aggregate purchase amount
$10,000
Total amount paid for reported common stock purchase
Time-based warrant shares
3,125 shares
Common Stock Purchase Warrant exercisable 2026-08-10 to 2029-08-10
Milestone warrant shares
3,125 shares
Common Stock Purchase Warrant (Milestone) granted August 7, 2026
Warrant exercise price
$2.95 per share
Exercise price for both warrants, subject to adjustment
Milestone revenue threshold
$1,500,000
Required U.S. revenue in any fiscal quarter for milestone warrant exercisability
Milestone earliest date
August 10, 2027
First possible date for Milestone Date determining milestone warrant exercisability
Key Terms
Common Stock Purchase Warrant, Milestone Date, volume-weighted average price, Nasdaq Capital Market, +1 more
5 terms
Common Stock Purchase Warrant financial
"Holder may, at its option, exercise the Common Warrant..."
A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.
Milestone Date financial
"The Common Warrant (Milestone) is exercisable only from and after the Milestone Date..."
volume-weighted average price financial
"the volume-weighted average price of the Common Stock has satisfied certain price conditions..."
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
Nasdaq Capital Market market
"subject to certain limitations, in accordance with rules of the Nasdaq Capital Market."
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
registration statement registering the resale regulatory
"three years after the effective date of a registration statement registering the resale of the Warrant Shares..."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did FEMY’s CTO Jeremy Alexander Sipos report on August 7, 2026?
Jeremy Alexander Sipos reported buying 3,125 FEMY common shares and receiving two warrants for 3,125 shares each. One warrant is time-based, and the other is tied to future revenue and price milestones.
What are the key terms of the FEMY warrant granted to the CTO on August 7, 2026?
One warrant covers 3,125 shares at an exercise price of $2.95 per share, exercisable at the holder’s option from August 10, 2026 until August 10, 2029, subject to Nasdaq Capital Market limitations on exercise.
Are there limitations on the CTO’s ability to exercise the FEMY warrants?
Yes. A footnote states the holder’s ability to exercise the warrants for shares of common stock is subject to certain limitations, consistent with rules of the Nasdaq Capital Market. These constraints apply when exercising into common shares.
Is the expiration date of the FEMY milestone warrant fixed?
The milestone warrant’s expiration is contingent. It expires on the earlier of three years after effectiveness of a resale registration statement or 45 days after notice that the Milestone Date occurred; both dates are not yet determinable.